Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis

BACKGROUND: Olanzapine has been reported to be an effective antiemetic in patients receiving carboplatin-based chemotherapy. However, the efficacy of a neurokinin-1 receptor antagonist (NK(1)RA) added to olanzapine, a 5-hydroxytryptamine-3 receptor antagonist (5-HT(3)RA), and dexamethasone (DEX) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Senri, Iihara, Hirotoshi, Uozumi, Ryuji, Kawazoe, Hitoshi, Tanaka, Kazuki, Fujita, Yukiyoshi, Abe, Masakazu, Imai, Hisao, Karayama, Masato, Hayasaki, Yoh, Hirose, Chiemi, Suda, Takafumi, Nakamura, Kazuto, Suzuki, Akio, Ohno, Yasushi, Morishige, Ken-ichirou, Inui, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941806/
https://www.ncbi.nlm.nih.gov/pubmed/35321690
http://dx.doi.org/10.1186/s12885-022-09392-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941806/
https://www.ncbi.nlm.nih.gov/pubmed/35321690
http://dx.doi.org/10.1186/s12885-022-09392-9

Ejemplares similares